GLOBAL OPHTHALMOLOGY DRUGS AND DEVICES MARKET FORECAST 2018-2026

  • You are here:
  • Home
  • Reports
  • GLOBAL OPHTHALMOLOGY DRUGS AND DEVICES MARKET FORECAST 2018-2026

GLOBAL OPHTHALMOLOGY DRUGS AND DEVICES MARKET FORECAST 2018-2026

The Global Ophthalmology Drugs and Devices market is anticipated to grow at a CAGR of 5.97% between 2018 and 2026. Ophthalmic Devices and Drugs are used in the documentation and conduct of definite ocular deficits and malformations of the eyes. The Ophthalmic Drugs and Devices market is chiefly compelled by the following factors: The global increase in prevalence rates of eye diseases

GLOBAL OPHTHALMOLOGY DRUGS AND DEVICES MARKET FORECAST 2018-2026

Global Ophthalmology Drugs & Devices Market Is Segmented by Ophthalmic Devices(Diagnostic & Monitoring Equipment, Surgery Device) by Vision Care(Contact Lens, Spectacles, Eye Exams) by Ophthalmic Drugs( by Prescription Type, by Drug Delivery Types, by Type of Disease, by Therapeutics) by End User(Hospitals, Eye Clinics, Diagnostic Centers, Patients) & Geography

Request free sample

The Global Ophthalmology Drugs and Devices market is anticipated to grow at a CAGR of 5.97% between 2018 and 2026. Ophthalmology devices and drugs are used in the documentation and conduct of definite ocular deficits and malformations of the eyes. The Ophthalmology drugs and devices market is chiefly compelled by the following factors:

  • The global increase in prevalence rates of eye diseases
  • Increasing prevalence of diabetes increases the probability of Ophthalmology disorders
  • Increasing geriatric population globally
  • Technological advancement
  • Increase in healthcare expenditure

Global Ophthalmology Drugs and Devices Market

To learn more about this report, request a free sample copy

The important driver increasing growth in the global Ophthalmology drugs and devices market is the global increase in the prevalence rates of eye diseases. Global Ophthalmology drugs and devices market is compelled by increasing occurrence of eye ailments such as diabetic retinopathy, macular degeneration, cataract, glaucoma, and visualization care devices. Ophthalmology devices are also used in medical procedures such as ultrasound phacoemulsification for sooner reclamation rates and better safety. An extensive choice of Ophthalmology devices and drugs are accessible in the market for the cure of eye disorders.

The Ophthalmology drugs and devices are used extensively for eye treatment and cure. Ophthalmology drugs & devices market refers to the market of devices and drugs that are used for the treatment of several Ophthalmology diseases such as astigmatism, near-sightedness, cataract, diabetic retinopathy, glaucoma, uveitis, etc. Some of the key devices used for diagnostic and monitoring in the global ophthalmology drugs & devices market include optical coherence tomography (OCT) scanners, Ophthalmology ultrasound imaging systems, fundus camera, ophthalmoscopes, retinoscope and others. The vision care market comprises of contact lenses such as single-day usage contact lens, bi-weekly usage contact lens, and eyeglasses comprise of single vision eyeglasses, bifocal eyeglasses, and progressive eyeglasses. Several drugs are already available in the market such as glaucoma drug, dry eye drug, allergic conjunctivitis drugs, and inflammation and conjunctivitis retinal disorder treatment drugs for the treatment of Ophthalmology diseases.

Renowned Drugs Going Off-Patent and Delay in Drug Approvals are the major factors hindering the Ophthalmology drugs and devices market. The various major drugs that have gone off-patent due to a string of patent expiries include Pfizer’s Xalatan, Alphagan P, Allergan’s Lumigan and others. Pfizer’s Xalatan is amongst one of the most prescribed drugs for the treatment of glaucoma, and it went off patent in 2010. The number of drugs in pipeline and delay in drug approval is acting as a major concern for the key players of the Ophthalmology drugs market.

The Global Ophthalmology drugs and devices market segments include drugs and devices

Drugs And Devices are segmented into:

  • Devices
    • Diagnostic & monitoring equipment
      • Optical coherence tomography
      • Ophthalmology ultrasound imaging systems
      • Fundus camera market
      • Ophthalmoscopes
      • Retinoscope
      • Pachymeter
      • Wavefront aberrometer
      • Perimeters/visual field analyzer
      • Autorefractors/phoropter
      • Specular microscope
      • Corneal topographers
      • Other diagnostic & monitoring equipment market
    • Surgery device
      • Cataract surgery devices
      • Glaucoma surgery devices
      • Refractive surgery devices
      • Vitreoretinal surgery devices
    • Vision care
  • Drugs
    • Glaucoma drug
    • Retinal disorder drug
    • Dry eye drug
    • Inflammation, Allergic conjunctivitis, and conjunctivitis drug
    • Drugs by use of preservation
      • Preserved drugs
      • Preservative-free drugs

This report covers the present market conditions and the growth prospects of the global Ophthalmology drugs and devices market for 2018-2026 and considered the revenue generated through the sales of Ophthalmology drugs and devices to calculate the market size by considering 2017 as the base year.

Geographically, the global Ophthalmology drugs and devices market has been segmented on the basis of four major regions, which include:

The Ophthalmology drugs and devices market in North America is expected to hold the largest share by 2026 owing to the rising number of studies based on ophthalmology disease, various grants and funding to support ophthalmology research and high prevalence of diabetes in a region. As a result, the demand for ophthalmology drug & devices would rise, which is expected to boost ophthalmology drug & devices market in North America during the forecast period. On the other hand, the Asia-Pacific market is anticipated to be the fastest-growing region for the Ophthalmology drugs and devices market. The Asia-Pacific ophthalmology drug & devices market is expected to be on the up-surging trend owing to government programs and meetings promoting research on ophthalmology, rising prevalence of cataracts, rising ageing population, growing number of cataract surgeries and rising medical tourism which is expected to boost the ophthalmology drug & devices market in the Asia-Pacific.

The major market players in the global Ophthalmology drugs and devices market are:

  • ALLERGAN INC.
  • CARL ZEISS AG
  • JOHNSON & JOHNSON INC.
  • PFIZER
  • SUN PHARMACEUTICALS INDUSTRIES LTD

Company Profiles covers analysis of important players.

Allergan Inc. (Allergan) is an Ireland based company, headquartered in Dublin. The company has a speciality in pharmaceuticals, with a primary focus on developing, manufacturing, marketing and distributing speciality branded, biosimilar, and over-the-counter (OTC) products. Sun Pharmaceuticals Industries Ltd is one of the world’s largest generic pharmaceutical organization and India’s top company. The company has vertically integrated business structure.

Key Findings of the Global Ophthalmology drugs and devices market:

  • Vision care devices are dominating the market
  • North America is the market leader
  • Glaucoma drugs are majorly used
  • Rising prevalence of eye-related diseases
  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • VISION CARE DEVICES ARE DOMINATING THE MARKET
      • NORTH AMERICA IS THE MARKET LEADER
      • GLAUCOMA DRUGS ARE MAJORLY USED
      • RISING PREVALENCE OF EYE RELATED DISEASES
  1. MARKET DETERMINANTS
    • MARKET DRIVERS
      • GLOBAL INCREASE IN PREVALENCE RATES OF EYE DISEASES
      • INCREASING PREVALENCE OF DIABETES INCREASES PROBABILITY OF OPHTHALMIC DISORDERS
      • INCREASING GERIATRIC POPULATION GLOBALLY
      • TECHNOLOGICAL ADVANCEMENT
      • INCREASE IN HEALTHCARE EXPENDITURE
    • MARKET RESTRAINTS
      • RENOWNED DRUGS GOING OFF-PATENT
      • DELAY IN DRUG APPROVALS
      • AWARENESS RELATED TO OPHTHALMOLOGY DRUGS ARE LOW
    • MARKET OPPORTUNITIES
      • INCREASE IN DISORDER SYMPTOM AND IMPROVED DIAGNOSIS LEADING TO HIGHER TREATMENT RATES
      • GROWING OPPORTUNITIES IN DEVELOPING ECONOMIES
      • INCREASING DEMAND FOR INTRAOCULAR LENSES AND PHACOEMULSIFICATION DEVICES
    • MARKET CHALLENGES
      • SLOW GROWTH IN THE DOMESTIC ECONOMY
      • VARIOUS RISK AND COMPLICATIONS ASSOCIATED WITH THE TREATMENT OF OCULAR DISEASES
  1. MARKET SEGMENTATION
    • MARKET BY DRUGS AND DEVICES 2018-2026
      • DEVICES
        • DIAGNOSTIC & MONITORING EQUIPMENT
          • OPTICAL COHERENCE TOMOGRAPHY
          • OPHTHALMIC ULTRASOUND IMAGING SYSTEMS
          • FUNDUS CAMERA MARKET
          • OPHTHALMOSCOPES
          • RETINOSCOPE
          • PACHYMETER
          • WAVEFRONT ABERROMETERS
          • PERIMETERS/VISUAL FIELD ANALYZER
          • AUTOREFRACTORS/PHOROPTER
          • SPECULAR MICROSCOPE
          • CORNEAL TOPOGRAPHERS
          • OTHER DIAGNOSTIC & MONITORING EQUIPMENT MARKET
        • SURGERY DEVICE
          • CATARACT SURGERY DEVICES
          • GLAUCOMA SURGERY DEVICES
          • REFRACTIVE SURGERY DEVICES
          • VITREORETINAL SURGERY DEVICES
        • VISION CARE
      • DRUGS
        • GLAUCOMA DRUG
        • RETINAL DISORDER DRUG
        • DRY EYE DRUG
        • ALLERGIC CONJUNCTIVITIS, INFLAMMATION AND CONJUNCTIVITIS DRUG
        • DRUGS BY USE OF PRESERVATION
          • PRESERVED DRUGS
          • PRESERVATIVE FREE DRUGS
  1. KEY ANALYTICS
    • PORTER’S FIVE FORCES ANALYSIS
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIER
      • THREATS OF NEW ENTRANTS
      • THREATS OF SUBSTITUTES
      • COMPETITIVE RIVALRY
    • VALUE CHAIN ANALYSIS
      • RESEARCH AND DEVELOPMENT
      • MANUFACTURING
      • DISTRIBUTORS
      • END USERS
    • STRATEGIC ANALYSIS
    • KEY BUYING CRITERIA
      • COST
      • EFFICACY
      • ACCESSIBILITY
      • INNOVATION
    • SUPPLY CHAIN ANALYSIS
      • SUPPLIERS
      • MANUFACTURERS
      • DISTRIBUTORS AND RETAILERS
      • END USERS
    • REGULATORY FRAMEWORK
    • ESTIMATION ANALYSIS
    • PARENT MARKET ANALYSIS
    • INVESTMENT ANALYSIS
  2. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • THE UK
      • FRANCE
      • GERMANY
      • SPAIN
      • ITALY
      • REST OF EUROPE
    • ASIA PACIFIC
      • INDIA
      • CHINA
      • JAPAN
      • SOUTH KOREA
      • AUSTRALIA
      • REST OF APAC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND NORTH AFRICA (MENA)
      • REST OF AFRICA
  1. COMPANY PROFILES
    • COMPETITIVE ANALYSIS
      • MARKET SHARE ANALYSIS
      • TOP COMPANIES
        • ESSILOR INTERNATIONAL S.A. (FRANCE)
        • JOHNSON & JOHNSON INC. (U.S.)
        • ALLERGAN PLC (U.S.)
        • NOVARTIS INTERNATIONAL AG (SWITZERLAND)
        • VALENT PHARMACEUTICALS INTERNATIONAL INC. (U.S.)
      • ALLERGAN INC.
        • COMPANY OVERVIEW
        • PRODUCT & SERVICES
        • SWOT ANALYSIS
        • STRATEGIC INITIATIVES
      • BAYER
        • COMPANY OVERVIEW
        • PRODUCT & SERVICES
        • SWOT ANALYSIS
        • STRATEGIC INITIATIVES
      • CARL ZEISS AG
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SWOT ANALYSIS
        • STRATEGIC INITIATIVE
      • ESSILOR INTERNATIONAL S.A.
        • COMPANY OVERVIEW
        • PRODUCT & SERVICES
        • SWOT ANALYSIS
        • STRATEGIC INITIATIVE
      • GLAXOSMITHKLINE
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SWOT ANALYSIS
      • JOHNSON & JOHNSON INC.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • NOVARTIS INTERNATIONAL AG
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • PFIZER
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • ROCHE HOLDING AG
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • SANTEN PHARMACEUTICAL CO., LTD.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVE
      • SUN PHARMACEUTICALS INDUSTRIES, LTD
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVE
      • VALENT PHARMACEUTICALS INTERNATIONAL INC.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVE
      • ZIEMER GROUP HOLDING AG
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVE

 

LIST OF TABLES

TABLE 1       GLOBAL OPTHALMOLOGY DRUGS AND DEVICES MARKET BY GEOGRAPHY 2018-2026

TABLE 2       PREVALENCE OF EYE DISEASES IN US 2014 & 2030

TABLE 3       NUMBER OF CATARACT SURGERIES UNDER GLOBAL ACTION PLAN 2014-2019 (GAP)

TABLE 4       COMMON CAUSES OF LOSS OF VISION IN THE ELDERLY

TABLE 5       SELECTED LIST OF GLAUCOMA DRUGS IN LATE-STAGE CLINICAL TRIALS

TABLE 6       EYE DRUGS GONE OFF-PATENT

TABLE 7       GLOBAL OPTHALMOLOGY DRUGS AND DEVICES MARKET BY DRUGS AND DEVICES 2018-2026 ($ MILLION)

TABLE 8       GLOBAL DRUGS AND DEVICES MARKET IN DEVICES 2018-2026 ($ MILLION)

TABLE 9       GLOBAL DEVICES MARKET IN DIAGNOSTIC & MONITORING EQUIPMENT  BY TYPES 2018-2026 ($ MILLION)

TABLE 10     GLOBAL DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OPTICAL COHERENCE TOMOGRAPHY BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 11     GLOBAL DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OPHTHALMIC ULTRASOUND IMAGING SYSTEMS BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 12     GLOBAL DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN FUNDUS CAMERA MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 13     GLOBAL DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OPHTHALMOSCOPES BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 14     GLOBAL DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN RETINOSCOPE BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 15     GLOBAL DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN PACHYMETER BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 16     GLOBAL DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN WAVEFRONT ABERROMETERS BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 17     GLOBAL DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN PERIMETERS/VISUAL FIELD ANALYZER BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 18     GLOBAL DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN AUTOREFRACTORS/PHOROPTER BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 19     GLOBAL DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN SPECULAR MICROSCOPE BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 20     GLOBAL DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN CORNEAL TOPOGRAPHERS BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 21     GLOBAL DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OTHER DIAGNOSTIC & MONITORING EQUIPMENT MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 22     GLOBAL DEVICES MARKET IN SURGERY DEVICE BY TYPES 2018-2026 ($ MILLION)

TABLE 23     GLOBAL SURGERY DEVICES MARKET IN CATARACT SURGERY DEVICES BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 24     GLOBAL SURGERY DEVICES MARKET IN GLAUCOMA SURGERY DEVICES BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 25     GLOBAL SURGERY DEVICES MARKET IN REFRACTIVE SURGERY DEVICES BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 26     GLOBAL SURGERY DEVICES MARKET IN VITREORETINAL SURGERY DEVICES BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 27     GLOBAL DEVICES MARKET IN VISION CARE MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 28     GLOBAL DRUGS AND DEVICES MARKET IN DRUGS BY TYPES 2018-2026 ($ MILLION)

TABLE 29     GLOBAL DRUGS MARKET IN GLAUCOMA DRUG BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 30     GLOBAL DRUGS MARKET IN RETINAL DISORDER DRUG BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 31     GLOBAL DRUGS MARKET IN DRY EYE DRUG BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 32     GLOBAL DRUGS MARKET IN ALLERGIC CONJUNCTIVITIS,  INFLAMMATION AND CONJUNCTIVITIS DRUG BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 33     GLOBAL DRUGS MARKET IN DRUGS BY USE OF PRESERVATION  2018-2026 ($ MILLION)

TABLE 34     GLOBAL DRUGS BY USE OF PRESERVATION IN PRESERVATIVE FREE DRUGS BY DOSES 2018-2026 ($ MILLION)

TABLE 35     GLOBAL DRUGS BY USE OF PRESERVATION IN PRESERVATIVE FREE DRUGS 2018-2026 ($ MILLION)

TABLE 36     GLOBAL OPTHALMOLOGY DRUGS AND DEVICES MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 37     NORTH AMERICA OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

TABLE 38     EUROPE OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

TABLE 39     ASIA PACIFIC OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

TABLE 40     REST OF WORLD OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

LIST OF FIGURES

FIGURE 1     GLOBAL OPTHALMOLOGY DRUGS AND DEVICES MARKET BY GEOGRAPHY 2018-2026

FIGURE 2     PREVALENCE OF DIABETES BY AGE GROUP (MILLIONS)

FIGURE 3     THE POPULATION OF PEOPLE AGED 65 AND OVER WILL DOUBLE IN THE NEXT 25 YEARS (IN MILLIONS)

FIGURE 4     PROJECTIONS FOR THE PROPORTION OF GERIATRIC (60+) POPULATION IN 2015, 2030 & 2050

FIGURE 5     GLOBAL DRUGS AND DEVICES MARKET IN DEVICES 2018-2026 ($ MILLION)

FIGURE 6     GLOBAL DEVICES MARKET DIAGNOSTIC & MONITORING EQUIPMENT  IN 2018-2026 ($ MILLION)

FIGURE 7     GLOBAL DEVICES MARKET IN SURGERY DEVICE 2018-2026 ($ MILLION)

FIGURE 8     GLOBAL DEVICES MARKET IN VISION CARE MARKET 2018-2026 ($ MILLION)

FIGURE 9     GLOBAL DRUGS AND DEVICES MARKET IN DRUGS 2018-2026 ($ MILLION)

FIGURE 10   GLOBAL DRUGS MARKET IN GLAUCOMA DRUG 2018-2026 ($ MILLION)

FIGURE 11   GLOBAL DRUGS MARKET IN RETINAL DISORDER DRUG 2018-2026 ($ MILLION)

FIGURE 12   GLOBAL DRUGS MARKET IN DRY EYE DRUG 2018-2026 ($ MILLION)

FIGURE 13   GLOBAL DRUGS MARKET IN ALLERGIC  CONJUNCTIVITIS,  INFLAMMATION AND CONJUNCTIVITIS DRUG 2018-2026 ($ MILLION)

FIGURE 14   GLOBAL DRUGS BY USE OF PRESERVATION  IN PRESERVED DRUGS 2018-2026 ($ MILLION)

FIGURE 15   GLOBAL PRESERVED FREE DRUGS MARKET IN SINGLE-DOSE 2018-2026 ($ MILLION)

FIGURE 16   GLOBAL PRESERVED FREE DRUGS MARKET IN MULTI-DOSE 2018-2026 ($ MILLION)

FIGURE 17   NUMBER OF POPULATION WITH DIABETES 2015 & 2040 (IN MILLION)

FIGURE 18   NORTH AMERICA OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

FIGURE 19   THE UNITED STATES OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

FIGURE 20   CANADA OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

FIGURE 21   EUROPE OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

FIGURE 22   THE UK OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

FIGURE 23   FRANCE OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

FIGURE 24   GERMANY OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

FIGURE 25   SPAIN OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

FIGURE 26   ITALY OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

FIGURE 27   REST OF EUROPE OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

FIGURE 28   ASIA PACIFIC OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

FIGURE 29   INDIA OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

FIGURE 30   CHINA OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

FIGURE 31   JAPAN OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

FIGURE 32   SOUTH KOREA OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

FIGURE 33   AUSTRALIA OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

FIGURE 34   REST OF APAC OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

FIGURE 35   REST OF WORLD OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

FIGURE 36   LATIN AMERICA OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

FIGURE 37   MENA OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

FIGURE 38   REST OF AFRICA OPTHALMOLOGY DRUGS AND DEVICES MARKET 2018-2026 ($ MILLION)

FIGURE 39   GLOBAL OPHTHALMOLOGY DEVICES COMPANY MARKET SHARE 2017 (%)

FIGURE 40   GLOBAL OPHTHALMOLOGY DRUGS COMPANY MARKET SHARE 2017 (%)

  1. MARKET SEGMENTATION
    • MARKET BY DRUGS AND DEVICES 2018-2026
      • DEVICES
        • DIAGNOSTIC & MONITORING EQUIPMENT
          • OPTICAL COHERENCE TOMOGRAPHY
          • OPHTHALMIC ULTRASOUND IMAGING SYSTEMS
          • FUNDUS CAMERA MARKET
          • OPHTHALMOSCOPES
          • RETINOSCOPE
          • PACHYMETER
          • WAVEFRONT ABERROMETERS
          • PERIMETERS/VISUAL FIELD ANALYZER
          • AUTOREFRACTORS/PHOROPTER
          • SPECULAR MICROSCOPE
          • CORNEAL TOPOGRAPHERS
          • OTHER DIAGNOSTIC & MONITORING EQUIPMENT MARKET
        • SURGERY DEVICE
          • CATARACT SURGERY DEVICES
          • GLAUCOMA SURGERY DEVICES
          • REFRACTIVE SURGERY DEVICES
          • VITREORETINAL SURGERY DEVICES
        • VISION CARE
      • DRUGS
        • GLAUCOMA DRUG
        • RETINAL DISORDER DRUG
        • DRY EYE DRUG
        • ALLERGIC CONJUNCTIVITIS, INFLAMMATION AND CONJUNCTIVITIS DRUG
        • DRUGS BY USE OF PRESERVATION
          • PRESERVED DRUGS
          • PRESERVATIVE FREE DRUGS
  1. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • THE UK
      • FRANCE
      • GERMANY
      • SPAIN
      • ITALY
      • REST OF EUROPE
    • ASIA PACIFIC
      • INDIA
      • CHINA
      • JAPAN
      • SOUTH KOREA
      • AUSTRALIA
      • REST OF APAC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND NORTH AFRICA (MENA)
      • REST OF AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now